Altubar, Norberto S.

HRN: 28-99-47  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/14/2026
05/19/2026
IV
300 MG
Q8
INFECTED DM FOOT
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: